Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Shinozaki

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Forensic Sciences|October 2, 2002
A discrimination method for paper by Fourier transform and cross correlationHitomi Miyata, Makoto Shinozaki, Tomohito Nakayama, et al.
Journal of Pharmacological Sciences|June 21, 2023
Characterization of electropharmacological profile of an anti-atrial fibrillatory drug vernakalant along with potential risk toward torsade de pointes: Translational studies using isoflurane-anesthetized dogs and isolated rat aortic preparationsAi Goto, Ryuichi Kambayashi, Hiroko Izumi-Nakaseko, et al.
Journal of Pharmacological Sciences|September 23, 2024
In vivo cardiovascular profile of ryanodine receptor 2 inhibitor M201-A: Utility as an anti-atrial fibrillatory drug for patients suffering from heart failure with preserved ejection fractionRyuichi Kambayashi, Ai Goto, Makoto Shinozaki, et al.
Journal of Pharmacological Sciences|March 14, 2024
Analyses of the onset mechanisms of cardio-stimulatory action by aciclovirAi Goto, Ryuichi Kambayashi, Koki Chiba, et al.
Journal of Pharmacological Sciences|March 18, 2022
Analysis of clinically-reported, memantine-induced cardiovascular adverse responses using the halothane-anesthetized dogs: Reverse translational studyRyuichi Kambayashi, Ai Goto, Mihoko Hagiwara-Nagasawa, et al.
Acta Neuropathologica|February 9, 2010
Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entityYong-Juan Fu, Yasushi Nishihira, Shigetoshi Kuroda, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2025
Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillationNoboru Kaneko, Godfrey L Smith, Christopher M Loughrey, et al.
British Journal of Pharmacology|May 21, 2024
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I studyNoboru Kaneko, Christopher M Loughrey, Godfrey Smith, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Forensic Sciences|October 2, 2002
A discrimination method for paper by Fourier transform and cross correlationHitomi Miyata, Makoto Shinozaki, Tomohito Nakayama, et al.
Journal of Pharmacological Sciences|June 21, 2023
Characterization of electropharmacological profile of an anti-atrial fibrillatory drug vernakalant along with potential risk toward torsade de pointes: Translational studies using isoflurane-anesthetized dogs and isolated rat aortic preparationsAi Goto, Ryuichi Kambayashi, Hiroko Izumi-Nakaseko, et al.
Journal of Pharmacological Sciences|September 23, 2024
In vivo cardiovascular profile of ryanodine receptor 2 inhibitor M201-A: Utility as an anti-atrial fibrillatory drug for patients suffering from heart failure with preserved ejection fractionRyuichi Kambayashi, Ai Goto, Makoto Shinozaki, et al.
Journal of Pharmacological Sciences|March 14, 2024
Analyses of the onset mechanisms of cardio-stimulatory action by aciclovirAi Goto, Ryuichi Kambayashi, Koki Chiba, et al.
Journal of Pharmacological Sciences|March 18, 2022
Analysis of clinically-reported, memantine-induced cardiovascular adverse responses using the halothane-anesthetized dogs: Reverse translational studyRyuichi Kambayashi, Ai Goto, Mihoko Hagiwara-Nagasawa, et al.
Acta Neuropathologica|February 9, 2010
Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entityYong-Juan Fu, Yasushi Nishihira, Shigetoshi Kuroda, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2025
Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillationNoboru Kaneko, Godfrey L Smith, Christopher M Loughrey, et al.
British Journal of Pharmacology|May 21, 2024
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I studyNoboru Kaneko, Christopher M Loughrey, Godfrey Smith, et al.
Pageof 1